-
Start Preamble
ACTION:
Notice of registration.
SUMMARY:
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration as importers of various classes of schedule I or II controlled substances.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.
Company FR Docket Published ABBVIE, LTD 82 FR 56994 December 1, 2017. VHG Labs DBA LGC Standard Warehouse 82 FR 58654 December 13, 2017. The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of Start Printed Page 4686schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons.
Start SignatureDated: January 26, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-02006 Filed 1-31-18; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 02/01/2018
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of registration.
- Document Number:
- 2018-02006
- Pages:
- 4685-4686 (2 pages)
- Docket Numbers:
- Docket No. DEA-392
- PDF File:
- 2018-02006.pdf